|
Age at Diagnosis
|
Menopause Status
|
ASTRO Category
|
Size
|
Histology
|
Grade
|
Biomarker Pattern
|
Node Biopsy
|
Adjuvant Treatment
|
Radiation Modality
|
Initial Failure
|
Failure (months)
|
Salvage Treatment
|
Current Status
|
|---|
|
61.7
|
Post
|
cautionary
|
1.00
|
DCIS
|
II
|
+/-/?
|
No
|
R + E
|
APBI
|
Local - E
|
20.3
|
MRM + C + E
|
NED
|
|
62.1
|
Post
|
acceptable
|
0.30
|
IDC
|
I
|
+/+/-
|
Yes
|
R + E
|
APBI
|
Local - T
|
45.3
|
MRM + C
|
NED
|
|
66.8
|
Post
|
acceptable
|
1.00
|
IDC
|
II
|
+/+/-
|
Yes
|
R + E
|
APBI
|
Local - E
|
59.6
|
SM
|
NED
|
|
69.3
|
Post
|
acceptable
|
2.00
|
IDC
|
II
|
+/-/-
|
Yes
|
R + E
|
APBI
|
Local - E
|
38.2
|
PM + C + WBI + E
|
NED
|
|
59.5
|
Post
|
cautionary
|
2.00
|
IDC
|
II
|
+/-/-
|
Yes
|
R + E + C
|
APBI
|
Local - E
|
47.1
|
MRM + C + E
|
NED
|
|
68.2
|
Post
|
cautionary
|
0.90
|
IDC
|
III
|
-/-/-
|
Yes
|
R
|
WBI
|
Local - E
|
49.5
|
MRM
|
NED
|
|
57.0
|
Post
|
cautionary
|
1.50
|
IDC
|
III
|
-/-/-
|
Yes
|
R + C
|
WBI
|
Local - T
|
5.2
|
SM
|
NED
|
|
56.5
|
Post
|
cautionary
|
0.90
|
DCIS
|
III
|
+/+/?
|
No
|
R
|
WBI
|
Local - T
|
49.3
|
SM
|
NED
|
|
62.3
|
Post
|
acceptable
|
0.60
|
IDC
|
II
|
+/+/-
|
Yes
|
R + E
|
WBI
|
Local - E
|
97.5
|
MRM + E
|
NED
|
|
45.4
|
Pre
|
unsuitable
|
3.00
|
IDC
|
II
|
+/+/-
|
Yes
|
R + E + C
|
APBI
|
Regional
|
55.0
|
SR + C
|
Expired
|
|
53.6
|
Post
|
cautionary
|
3.00
|
IDC
|
II
|
+/+/-
|
Yes
|
R + E
|
APBI
|
Regional
|
17.1
|
SR + C + R
|
NED
|
|
70.7
|
Post
|
cautionary
|
0.80
|
IDC
|
III
|
-/-/-
|
Yes
|
R
|
APBI
|
Metastatic
|
32.4
|
C + H
|
Expired
|
|
68.6
|
Post
|
cautionary
|
1.00
|
IDC
|
III
|
+/+/-
|
Yes
|
R
|
WBI
|
Metastatic
|
13.2
|
-
|
Expired
|
|
71.1
|
Post
|
cautionary
|
2.10
|
IDC
|
III
|
-/-/+
|
Yes
|
R + C
|
APBI
|
Metastatic
|
45.4
|
C + R
|
Under Treatment
|
|
56.5
|
Post
|
cautionary
|
2.90
|
IDC
|
III
|
+/+/+
|
Yes
|
R + C + E
|
APBI
|
Metastatic
|
60.8
|
R
|
Under Treatment
|
|
58.1
|
Post
|
cautionary
|
1.50
|
IDC
|
II
|
+/-/-
|
Yes
|
R
|
WBI
|
Metastatic
|
46.1
|
C
|
Under Treatment
|
- Abbreviations: SM simple mastectomy, MRM modified radical mastectomy, PM partial mastectomy, R radiotherapy, C chemotherapy, E endocrine therapy, H Herceptin, Local-T - true recurrence, Local-E - elsewhere recurrence. Biomarker pattern shows the status for estrogen receptor, progesterone receptor, and HER2/neu using the following symbolic code: (ER)/(PR)/(HER2/neu). Presence of the biomarker is indicated by '+,' absence by '-,' unknown by '?.'
